Early-onset colorectal cancer now leads the global burden of GI cancers among adults aged younger than 50 years, with ...

Clinical disease activity of Crohn disease among people with overweight or obesity was reduced with time-restricted feeding.

The FDA has announced a recall of more than 20,000 peanut butter products made by Ventura Foods because of possible plastic contamination.

Leadership from the NIH directed the NIAID to remove references to “biodefense” and “pandemic preparedness” from the NIAID website.

Bariatric surgery can have complex and varied effects on mental health — from improved QOL to increased long-term depression.

Topline data from the KEPLER study indicate that vedolizumab may offer a meaningful benefit for children as young as 2 years with active ulcerative colitis.

Predictive testing and preventative treatment appealed to patients with inflammatory bowel disease and their family members.

California, Colorado, Illinois, and Minnesota filed a lawsuit against the Trump administration for rescinding over $600 million of funding.

The FAST score has the strongest overall performance for identifying “at-risk” MASH, with magnetic resonance-based modalities offering reliable alternatives.

The FDA has approved Optune Pax for the treatment of adult patients with locally advanced pancreatic cancer alongside gemcitabine and nab-paclitaxel.

President Trump terminated the EPA’s 2009 endangerment finding, ending federal authority to limit greenhouse gas pollution for public health.

Deputy Secretary of HHS Jim O'Neill and General Counsel Mike Stuart will leave their posts amid changes meant to improve public messaging.